Showing results (291-300 of 558) with videos related to

Sort By:
Pageof 56
Bioorganic & Medicinal Chemistry|October 27, 2012
Discovery of novel 2-(3-(2-chlorophenyl)pyrazin-2-ylthio)-N-arylacetamides as potent HIV-1 inhibitors using a structure-based bioisosterism approachPeng Zhan, Wenmin Chen, Zhenyu Li, et al.
Chemical Biology & Drug Design|January 29, 2015
Synthesis and Biological Evaluation of a Series of 2-((1-substituted-1H-1,2,3-triazol-4-yl)methylthio)-6-(naphthalen-1-ylmethyl)pyrimidin-4(3H)-one As Potential HIV-1 InhibitorsZengjun Fang, Dongwei Kang, Lingzi Zhang, et al.
European Journal of Medicinal Chemistry|April 29, 2014
Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approachXiao Li, Wenmin Chen, Ye Tian, et al.
Expert Opinion on Therapeutic Patents|January 10, 2023
Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020-present)Xiaoyu Shi, Tong Zhao, Edeildo Ferreira da Silva-Júnior, et al.
Bioorganic & Medicinal Chemistry|June 21, 2011
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitorsJing Zhang, Peng Zhan, Jingde Wu, et al.
ACS Infectious Diseases|August 7, 2025
Structure-Based Drug Design Yields Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase InhibitorsZhenzhen Zhou, Jie Guo, Xin Li, et al.
European Journal of Medicinal Chemistry|August 30, 2011
Arylazolylthioacetanilide. Part 8: Design, synthesis and biological evaluation of novel 2-(2-(2,4-dichlorophenyl)-2H-1,2,4-triazol-3-ylthio)-N-arylacetamides as potent HIV-1 inhibitorsPeng Zhan, Xuwang Chen, Xiao Li, et al.
Bioorganic & Medicinal Chemistry Letters|March 29, 2014
Identification of novel SIRT2-selective inhibitors using a click chemistry approachPrima R Tatum, Hideyuki Sawada, Yosuke Ota, et al.
Chemical Biology & Drug Design|February 26, 2016
Arylazolyl(azinyl)thioacetanilides: Part 19: Discovery of Novel Substituted Imidazo[4,5-b]pyridin-2-ylthioacetanilides as Potent HIV NNRTIs Via a Structure-based Bioisosterism ApproachXiao Li, Boshi Huang, Zhongxia Zhou, et al.
European Journal of Medicinal Chemistry|November 13, 2024
Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profileJiaojiao Dai, Xiangyi Jiang, Heng Gao, et al.
Pageof 56